Thank you. I hope that everyone is well. I would like to join Philippe in the recognition of our people and add my thanks to them. As a reminder, my remarks will track to the presentation slides that accompany our webcast. On slide two, our increase in total revenue, which includes billable expenses, was 3.8%. Our third quarter revenue before billable expenses net revenue increased 1.5% and organic growth was 5.6%. We grew organically across all regions. The three-year organic stack in the quarter through the pandemic period is 16.9%, which demonstrates a historically strong momentum. Third quarter adjusted EBITA was $356.2 million with margin of 15.5% on net revenue. Diluted earnings per share was $0.64 as reported and $0.63 as adjusted. Adjustments exclude the after-tax impacts of the amortization of acquired intangibles a restructuring adjustment and a non-operating gain from dispositions of certain small agencies and a business investment. We repurchased 2.6 million of our common shares during the quarter worth $73.7 million bringing share repurchases to 7.1 million through the first nine months of the year. Turning to slide three to see our P&L for the quarter. I'll cover revenue and operating expenses in detail in the slides that follow. On slide four, we present net revenue in more detail. Our net revenue was $2.26 billion in the third quarter of 2021. Compared to Q3 2021, the impact of the change in exchange rates was negative 3.6% with the dollar stronger against currencies in nearly all of our international markets. The impact of net divestitures of certain small non-strategic businesses was negative 50 basis points. Our organic increase was 5.6%. The result was net revenue of $2.3 billion in this year's third quarter. Further down the slide, we break out segment net revenue performance. Our media, data engagement solutions segment grew 3.8% organically on top of 15.9% in the third quarter of 2021. As you can see on this slide, the segment is comprised of IPG Mediabrands, Acxiom, Kinesso and our digital specialist agency. At one end of the spectrum, IPG Mediabrands grew at a double-digit rate organically. While the other ends we experienced softness at R/GA and Huge, which weighed on our results both at the segment and IPG level. Organic growth at our integrated advertising and creatively led solutions segment was 6.7%, which was on top of 12.8% a year ago. As a reminder, this segment is comprised of IPG Health, McCann MullenLowe, FCB and our domestic integrated agencies. Our growth in the quarter was led by a strong increase at IPG Health, and solid growth at McCann. At our specialized communications and experiential solutions segment, organic growth was 7.8%, which compounds 18.5% in last year's third quarter. This segment is comprised of Weber Shandwick, Golin Jack Morton, Momentum, Octagon and DXTRA Health. We were led by double-digit increases in our experiential solutions and had mid-single-digit growth in our PR discipline. Slide 5 presents an organic change of net revenue by region. In the US, which was 66% of net revenue in the quarter, our organic increase was 4.4%. That is on top of 14.7% a year ago and was driven by disciplines and agencies, across the range of our offerings. We were led by IPG Health, IPG Mediabrands, Mediahub, Jack Morton and Momentum. International markets were 34% of our net revenue in the quarter and increased 7.8% organically. That is on top of 15.4% a year ago. Continental Europe increased 4.7%. We were led by growth across brands Italy, Spain and the Netherlands. Germany was down slightly in the quarter on top of 13% growth a year ago. The UK increased 4.9% organically. Our performance was led by media, experiential and IPG Health. Asia Pac grew 5.6% organically, with broad-based growth across our largest markets, including Australia, India, Singapore and China. Our organic growth in LatAm continued to be strong at 19.8%, which it's worth noting is on top of 20% growth a year ago. We grew across all of our principal markets, which include Brazil, Argentina, Mexico, Chile and Colombia. Our Other Markets group, which is made up of Canada, the Middle East and Africa grew 10.6%. We were led by double-digit growth in the Middle East and solid growth in Canada. Moving on to slide 6, and our operating expenses. Our adjusted EBITA margin on net revenue was 15.5% in the quarter, which as expected decreased from 16.3% a year ago. You'll recall that, last year's margin benefited from several transitory effects, which were due to both the sharp acceleration of revenue growth during 2021, and to the impact of the pandemic on certain operating expenses, which caused them to run at unusually low levels. These expenses include travel, meetings, and in-office work. You'll also recall that, our hiring significantly lagged behind our top line growth last year. I would point out that, our Q3 adjusted EBITA margin is well above the pre-pandemic third quarter of 2019, which was 14.7%. This slide depicts our principal expenses as a percent to net revenue this year and last year. As you can see, our ratio of total salaries and related expense as a percentage of net revenue was 67.4% in the quarter compared to 66.8% a year ago. Underneath the SRS result, we delivered – delivered on our expense for base payroll, benefits and tax, due to the hiring that is required to support our 9.1% organic growth over the trailing 12 months. Headcount increased approximately 7% over the same period. Going the other way, our expense for temporary labor decreased from a year ago, and our expense for performance-based employee incentive compensation also decreased significantly. At quarter end, our total worldwide headcount was approximately 58,500. Also, on this slide, our office and other direct expense was 14.3% of net revenue compared to 13.3% a year ago. We continue to leverage our expense for occupancy, which was 4.8% of revenue an improvement of 20 basis points from a year ago. All other office and other direct expense was 9.5% of net revenue compared with 8.3% a year ago. The comparison reflects the return of variable expenses that I referred to earlier as a result of increased levels of business activities so not fully up to pre-pandemic levels. Our SG&A expense was 0.8% of net revenue, a decrease of 60 basis points from a year ago. On slide 7 we present the detail on adjustments to our reported third quarter results in order to provide a picture of comparable performance. This begins on the left-hand side with our reported results and steps through to adjusted EBITA and our adjusted diluted EPS. Our expense for the amortization of acquired intangibles in the second quarter was $20.2 million. Our restructuring adjustment was a $5.8 million credit which here we have adjusted out of our results. Below operating expenses and shown in column five we had a net gain of $15 million due to the disposition of a few small non-strategic agencies and a business investment. At the foot of the slide you can see the after-tax impact per diluted share of each of these adjustments, which bridges our diluted EPS as reported at $0.64 to adjusted earnings of $0.63 per diluted share. Slide 8 depicts a similar set of adjustments for the nine months again for continuity and comparability. Adjusted diluted earnings per share is $1.73 for the period. On slide 9, we turn to cash flow in the quarter. Cash provided by operations was $65.6 million. Cash used for working capital was $276.1 million. Operating cash flow before working capital was $341.7 million. As a reminder, our operating cash flow is both highly seasonal as well as volatile by quarter due to changes in the working capital component. This is largely a function of the variability and the timing of our collections and payments. In our investing activities we used $36.4 million mainly for CapEx partially offset by the sale of a business investment. Our financing activities in the quarter is $209.8 million primarily for our common stock dividend and share repurchases. Our net decrease in cash for the quarter was $211 million and our cash position at quarter end was $1.77 billion. Slide 10 is the current portion of our balance sheet. Slide 11 depicts the maturities of our outstanding debt. As you can see on the schedule, total debt at quarter end remained at $3 billion. Our next maturity is April 2024 for only $250 million. Thereafter, our next maturity is not until 2028. Gross financial debt to EBITA as defined in our credit facility covenant was 1.7 times at quarter end. In summary on slide 12, our teams continue to execute at a high level and have us well positioned to deliver on our updated expectations for the year. I would like to reiterate our pride in and gratitude for the efforts of our people. The strength of our balance sheet and liquidity means that we remain well-positioned both financially and commercially. And with that, I'll turn it back to Philippe.